How Telehealth Can Maximize Access to Opioid Use Disorder Treatment

The COVID-19 pandemic significantly disrupted how people with opioid use disorder access lifesaving medications, with the federal government introducing temporary regulatory flexibilities to increase their availability through telehealth services. The FY2023 Omnibus legislation extended these flexibilities for two years, but without Congressional action they will expire at the end of next year, which will reduce patient access to proven treatment.   

Join us on Thursday, March 30 from 10:30 am-12 noon at the South Congressional Meeting Room (CVC 217) to learn more about the latest research on how telehealth helps prevents opioid overdose deaths, how providers and states successfully pivoted to ensure patients received high-quality care during the pandemic, and how making these regulatory flexibilities permanent is integral to addressing the overdose crisis.

This Congressional briefing is hosted by The Pew Charitable Trusts and presented in collaboration with the Congressional Addiction Treatment and Recovery Caucus.